Atorvastatin Calcium

Product NDC: 68180-638
11-digit product format: 681800638
Labeler code: 68180
Product ID: 68180-638_ab716c10-785b-4d43-a5f0-59f95b0b78c8
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Atorvastatin Calcium
Dosage form: TABLET
Route: ORAL
Labeler: Lupin Pharmaceuticals, Inc.
Application: ANDA204991
Marketing category: ANDA
Marketing start: 2020-09-24
Substance: ATORVASTATIN CALCIUM TRIHYDRATE
Active strength: 80 mg/1
Pharmacologic classes: HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	68180-638	68180-638-02	D	Discontinued by firm		2026-08-17
excluded package	package	68180-638	68180-638-09	D	Discontinued by firm		2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 23 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Package NDC, Snapshot table
Captured / source date	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	68180-638-09	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	68180-638-02	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	68180-638-09	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	68180-638-02	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	68180-638-09	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	68180-638-02	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	68180-638-09	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	68180-638-02	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	68180-638-09	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	68180-638-02	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	68180-638-09	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	68180-638-02	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	68180-638-09	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	68180-638-02	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	68180-638-09	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	68180-638-02	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	68180-638-09	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	68180-638-02	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	68180-638-09	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	68180-638-02	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	68180-638-09	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	68180-638-02	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	68180-638-02	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	Approval date
A204991-001	ATORVASTATIN CALCIUM	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	2019-03-06
A204991-002	ATORVASTATIN CALCIUM	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	2019-03-06
A204991-003	ATORVASTATIN CALCIUM	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	2019-03-06
A204991-004	ATORVASTATIN CALCIUM	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	2019-03-06

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 168 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A204991-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	2019-03-06	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A204991-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	2019-03-06	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A204991-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	2019-03-06	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A204991-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	2019-03-06	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A204991-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	2019-03-06	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A204991-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	2019-03-06	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A204991-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	2019-03-06	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A204991-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	2019-03-06	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A204991-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	2019-03-06	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A204991-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	2019-03-06	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A204991-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	2019-03-06	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A204991-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	2019-03-06	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A204991-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	2019-03-06	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A204991-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	2019-03-06	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A204991-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	2019-03-06	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A204991-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	2019-03-06	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A204991-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	2019-03-06	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A204991-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	2019-03-06	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A204991-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	2019-03-06	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A204991-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	2019-03-06	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A204991-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	2019-03-06	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A204991-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	2019-03-06	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A204991-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	2019-03-06	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A204991-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	2019-03-06	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A204991-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	2019-03-06	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A204991-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	2019-03-06	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A204991-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	2019-03-06	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A204991-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	2019-03-06	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A204991-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	2019-03-06	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A204991-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	2019-03-06	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A204991-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	2019-03-06	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A204991-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	2019-03-06	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A204991-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	2019-03-06	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A204991-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	2019-03-06	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A204991-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	2019-03-06	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A204991-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	2019-03-06	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A204991-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	2019-03-06	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A204991-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	2019-03-06	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A204991-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	2019-03-06	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A204991-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	2019-03-06	`d8e5a09893c0…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 112 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A204991-001	BX	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A204991-002	BX	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A204991-003	BX	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A204991-004	BX	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A204991-001	BX	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A204991-002	BX	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A204991-003	BX	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A204991-004	BX	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A204991-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A204991-002	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A204991-003	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A204991-004	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A204991-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A204991-002	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A204991-003	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A204991-004	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A204991-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A204991-002	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A204991-003	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A204991-004	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A204991-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A204991-002	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A204991-003	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A204991-004	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A204991-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A204991-002	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A204991-003	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A204991-004	AB	1	`4b0b4de00fa7…`
2022-03-09 01:35 UTC	2022-03	A204991-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A204991-002	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A204991-003	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A204991-004	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A204991-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A204991-002	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A204991-003	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A204991-004	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A204991-001	AB	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A204991-002	AB	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A204991-003	AB	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A204991-004	AB	1	`87673890dc5c…`

Additional Listing Data#

Finished product: Yes
Brand name base: Atorvastatin Calcium
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
ATORVASTATIN CALCIUM TRIHYDRATE	80 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
48A5M73Z4Q	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 4 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
259255	Internal RxNorm lookup
617310	Internal RxNorm lookup
617311	Internal RxNorm lookup
617312	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
a5767370-15a2-45e5-b980-7af9523aea7b	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
fa898d56-9495-d6f0-309b-68a5d8e3914a	Product name	4	20260305
d25cba4b-d79e-4890-8837-1382f7d09489	Product name	1	20231002
91774e91-b249-45e3-8ff8-4b5db2927a69	Product name	1	20230718
03fb3cda-d60a-4873-94e9-6fa77cfb1a1c	Product name	1	20220302
34152997-af0b-acf4-dcaf-37211afe8ca4	Product name	9	20210312
46fdf265-6d5a-1bfb-93db-d82a4ea8aa81	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
68180-638-02	Atorvastatin Calcium	500 in 1 BOTTLE	TABLET	500	17
68180-638-06	Atorvastatin Calcium	30 in 1 BOTTLE	TABLET	30	17
68180-638-09	Atorvastatin Calcium	90 in 1 BOTTLE	TABLET	90	17

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
68180-638	ATORVASTATIN CALCIUM TABLET [LUPIN PHARMACEUTICALS, INC.]	17	Current NDC, Legacy NDC, 3 package rows	20231216_a5767370-15a2-45e5-b980-7af9523aea7b.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 6 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
ATORVASTATIN CALCIUM	ATORVASTATIN CALCIUM	DIRECT RX	c3b70f79-45a3-0869-e053-2a95a90a3cdb	2025-01-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 204991 application number: ANDA204991
Atorvastatin Calcium	ATORVASTATIN CALCIUM	Bryant Ranch Prepack	5868d3c2-ae17-4a7e-9580-7c3cf9bf009e	2024-04-05	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 204991 application number: ANDA204991
Atorvastatin Calcium	ATORVASTATIN CALCIUM	Lupin Pharmaceuticals, Inc.	a5767370-15a2-45e5-b980-7af9523aea7b	2023-12-15	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 204991 application number: ANDA204991 ndc (product): 68180-638
Atorvastatin Calcium	ATORVASTATIN CALCIUM	A-S Medication Solutions	85c38e0b-3d0b-4b04-990a-ed077a4c43e4	2023-02-06	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 204991 application number: ANDA204991
Atorvastatin Calcium	ATORVASTATIN CALCIUM	A-S Medication Solutions	d3f27113-785c-419e-955a-d6782fade438	2023-02-06	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 204991 application number: ANDA204991
Atorvastatin Calcium	ATORVASTATIN CALCIUM	A-S Medication Solutions	f4154300-65d4-4e31-97ad-b8d086c676e2	2023-02-06	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 204991 application number: ANDA204991

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
48A5M73Z4Q	ATORVASTATIN CALCIUM TRIHYDRATE	344423-98-9	ATORVASTATIN CALCIUM TRIHYDRATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
617312	atorvastatin calcium 10 MG Oral Tablet	PSN	a5767370-15a2-45e5-b980-7af9523aea7b	17
617310	atorvastatin calcium 20 MG Oral Tablet	PSN	a5767370-15a2-45e5-b980-7af9523aea7b	17
617311	atorvastatin calcium 40 MG Oral Tablet	PSN	a5767370-15a2-45e5-b980-7af9523aea7b	17
259255	atorvastatin calcium 80 MG Oral Tablet	PSN	a5767370-15a2-45e5-b980-7af9523aea7b	17
617312	atorvastatin 10 MG Oral Tablet	SCD	a5767370-15a2-45e5-b980-7af9523aea7b	17
617310	atorvastatin 20 MG Oral Tablet	SCD	a5767370-15a2-45e5-b980-7af9523aea7b	17
617311	atorvastatin 40 MG Oral Tablet	SCD	a5767370-15a2-45e5-b980-7af9523aea7b	17
259255	atorvastatin 80 MG Oral Tablet	SCD	a5767370-15a2-45e5-b980-7af9523aea7b	17
617312	atorvastatin (as atorvastatin calcium) 10 MG Oral Tablet	SY	a5767370-15a2-45e5-b980-7af9523aea7b	17
617310	atorvastatin (as atorvastatin calcium) 20 MG Oral Tablet	SY	a5767370-15a2-45e5-b980-7af9523aea7b	17
617311	atorvastatin (as atorvastatin calcium) 40 MG Oral Tablet	SY	a5767370-15a2-45e5-b980-7af9523aea7b	17
259255	atorvastatin (as atorvastatin calcium) 80 MG Oral Tablet	SY	a5767370-15a2-45e5-b980-7af9523aea7b	17
259255	atorvastatin calcium 80 MG Oral Tablet	PSN	c67622db-2cc4-424d-e053-2a95a90ab401	1
259255	atorvastatin calcium 80 MG Oral Tablet	PSN	d160d04b-2081-9008-e053-2995a90a6721	1
259255	atorvastatin 80 MG Oral Tablet	SCD	c67622db-2cc4-424d-e053-2a95a90ab401	1
259255	atorvastatin 80 MG Oral Tablet	SCD	d160d04b-2081-9008-e053-2995a90a6721	1
259255	atorvastatin (as atorvastatin calcium) 80 MG Oral Tablet	SY	c67622db-2cc4-424d-e053-2a95a90ab401	1
259255	atorvastatin (as atorvastatin calcium) 80 MG Oral Tablet	SY	d160d04b-2081-9008-e053-2995a90a6721	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
68180-638-02	68180063802	500 TABLET in 1 BOTTLE (68180-638-02)	500 tablet	2020-09-24	0000-00-00	No	No	Current
68180-638-06	68180063806	30 TABLET in 1 BOTTLE (68180-638-06)	30 tablet	2020-09-24	0000-00-00	No	No	Current
68180-638-09	68180063809	90 TABLET in 1 BOTTLE (68180-638-09)	90 tablet	2020-09-24	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Atorvastatin Calcium	Lupin Pharmaceuticals, Inc. \| LUPIN LIMITED	2023-12-15	HUMAN PRESCRIPTION DRUG LABEL	17
Atorvastatin Calcium	A-S Medication Solutions	2023-02-06	HUMAN PRESCRIPTION DRUG LABEL	3
Atorvastatin Calcium	Preferred Pharmaceuticals, Inc.	2022-02-03	HUMAN PRESCRIPTION DRUG LABEL	1
Atorvastatin Calcium	DirectRx	2021-11-22	HUMAN PRESCRIPTION DRUG LABEL	1
Atorvastatin Calcium	NuCare Pharmaceuticals,Inc.	2021-07-06	HUMAN PRESCRIPTION DRUG LABEL	1